Abstract:Structures of DRD1-Gs in complex with catechol-based and non-catechol agonistsKey polar interaction network is involved in DRD1 activationSpecific features for agonists interaction and Gs coupling of DRD1 are determinedStructure of DRD1-Gs complexed with dopamine and positive allosteric modulatorStructural basis of allosteric regulation of DRD1 by LY3154207 is investigatedDopamine receptors, including D1- and D2-like receptors, are important therapeutic targets in a variety of neurological syndromes, as well as cardiovascular and kidney diseases. Here, we present five cryoelectron microscopy (cryo-EM) structures of the dopamine D1 receptor (DRD1) coupled to Gs heterotrimer in complex with three catechol-based agonists, a non-catechol agonist, and a positive allosteric modulator for endogenous dopamine. These structures revealed that a polar interaction network is essential for catecholamine-like agonist recognition, whereas specific motifs in the extended binding pocket were responsible for discriminating D1- from D2-like receptors. Moreover, allosteric binding at a distinct inner surface pocket improved the activity of DRD1 by stabilizing endogenous dopamine interaction at the orthosteric site. DRD1-Gs interface revealed key features that serve as determinants for G protein coupling. Together, our study provides a structural understanding of the ligand recognition, allosteric regulation, and G protein coupling mechanisms of DRD1.<ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S0092867421000714-fx1_lrg.jpg">Download : Download high-res image (304KB)</a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S0092867421000714-fx1.jpg">Download : Download full-size image</a></li></ol>

Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor

Computational insights into diverse binding modes of the allosteric modulator and their regulation on dopamine D1 receptor

Dopaminergic Pharmacology Revealed by Structures of Human Dopamine D3 Receptor-G I Complexes

Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1

Structural insights into the human D1 and D2 dopamine receptor signaling complexes

Structures of the human dopamine D3 receptor-Gi complexes

Intracellular Binding Site for a Positive Allosteric Modulator of the Dopamine D1 Receptor

Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes

Structural genomics of the human dopamine receptor system

Ligand recognition and biased agonism of the D1 dopamine receptor

Computational modeling toward understanding agonist binding on dopamine 3.

Structure-Based Discovery of a Novel Allosteric Inhibitor against Human Dopamine Transporter

Molecular Insights into Ago-Allosteric Modulation of the Human Glucagon-Like Peptide-1 Receptor

Dopamine reuptake and inhibitory mechanisms in human dopamine transporter

Selectivity and Activation of Dopamine D3R from Molecular Dynamics

Exploring the Putative Mechanism of Allosteric Modulations by Mixed-Action Kappa/mu Opioid Receptor Bitopic Modulators.

Allosteric Modulation of Cannabinoid Receptor 1—Current Challenges and Future Opportunities

Positive allosteric modulators of the dopamine D1 receptor: A new mechanism for the treatment of neuropsychiatric disorders.

Recent Advances Towards the Discovery of Dopamine Receptor Ligands

In Vitro Characterization of A Novel Allosteric Potentiator of the Dopamine D1 Receptor

Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist